UroGen Pharma (URGN) Net Margin Growth (1y) (2019 - 2026)
UroGen Pharma (URGN) Net Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 680.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn | 17,021.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,021.00 |
| Dec 31, 2025 | -4,490.00 |
| Sep 30, 2025 | -2,742.00 |
| Jun 30, 2025 | -5,335.00 |
| Mar 31, 2025 | -4,456.00 |
| Dec 31, 2024 | 9,311.00 |
| Sep 30, 2024 | 1,100.00 |
| Jun 30, 2024 | -3,871.00 |
| Mar 31, 2024 | 383.00 |
| Dec 31, 2023 | 4,142.00 |
| Sep 30, 2023 | 5,555.00 |
| Jun 30, 2023 | 4,657.00 |
| Mar 31, 2023 | 3,358.00 |
| Dec 31, 2022 | -14,814.00 |
| Sep 30, 2022 | 10,568.00 |
| Jun 30, 2022 | 4,046.00 |
| Mar 31, 2022 | 13,717.00 |
| Dec 31, 2021 | 37,178.00 |
| Sep 30, 2021 | 56,644.00 |
| Jun 30, 2021 | 822,594.00 |